# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-008600
Filing Date
2022-02-22
Accepted
2022-02-22 09:05:52
Documents
24
Period of Report
2022-02-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea155997-6k_scisparc.htm | 6-K | 11894
2 | CORPORATE PRESENTATION, DATED FEBRUARY 22, 2022 | ea155997ex99-1_scisparc.htm | EX-99.1 | 30330
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 113628
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 157692
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 99323
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 101993
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 75893
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 86255
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 88494
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 103595
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 123477
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 115595
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 146367
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 133280
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 140426
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 166583
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 141427
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 119127
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 73559
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 74362
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 143775
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 111244
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 135782
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 119181
| Complete submission text file | 0001213900-22-008600.txt |  | 3587387

Mailing Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916
Business Address 20 RAUL WALLENBERG STREET, TOWER A TEL AVIV L3 6971916 972-3-6103100
SciSparc Ltd. (Filer) CIK: 0001611746 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 22655442
SIC: 2834 Pharmaceutical Preparations